Oppenheimer Raises Amrize Target to $70 After $779M Q4 EBITDA
On February 19, Oppenheimer raised its Amrize target to $70 from $64 and maintained an Outperform rating after Q4 2025 EBITDA of $779M surpassed expectations. Wells Fargo and Berenberg also lifted targets to $66 and $70 respectively, citing a 4.5% shareholder yield and stronger-than-forecast 2026 guidance.
1. Analyst Price Target Increases
On February 19, Oppenheimer raised its Amrize price target to $70 from $64 and reiterated an Outperform rating. Wells Fargo boosted its target to $66 from $59 with an Overweight rating, and Berenberg lifted its target to $70 from $64, each citing stronger outlooks and shareholder returns.
2. Q4 Financial Performance
Amrize reported Q4 2025 EBITDA of $779M, exceeding consensus, while revenue was $2.84B versus a $2.92B forecast. CEO Jan Jenisch described 2025 as a milestone year after completing the spin-off and delivering robust free cash flow and profitability metrics.
3. Guidance and Outlook
The company issued 2026 revenue and profitability guidance moderately above Street expectations, underpinning analyst upgrades. Reports highlighted a bottom forming in the residential Building Envelope segment and multiple catalysts supporting sustained earnings growth.
4. Company Strategy and Segments
Amrize supplies building materials and building envelope solutions for infrastructure, commercial and residential markets in North America. Its proposed buyback and dividend program offers a 4.5% shareholder yield, reinforcing a commitment to capital returns and long-term value creation.